Multiple myeloma treatment

Multiple myeloma treatment

Our specialists are equipped to treat multiple myeloma, leveraging advanced treatments and medication to deliver effective care.

The right treatment for multiple myeloma depends on several factors. A hematologist (blood cancer specialist) can help you determine the best options based on:

  • Age
  • General health
  • Test results
  • Classification and stage of disease

The goals of multiple myeloma treatment may differ, depending on the exact diagnosis and personal circumstances:

  • Controlling the disease to preventing damage to organs and bones
  • Destroying all cancer cells
  • Managing a precancerous condition or multiple myeloma that's in remission (not active)
  • Providing relief from symptoms so you can live a full life for as long as possible

 

Multiple myeloma treatment options

Penn Medicine has every available option to treat this disease — from traditional cancer therapies to the newest treatments specifically for multiple myeloma. Options may include:

Multiple myeloma treatment at Penn Medicine

Multiple myeloma treatment: the Penn Medicine advantage

When you choose Penn Medicine's Blood Cancer Program for your multiple myeloma treatment, you'll find:

  • Innovative treatment options: We offer every type of treatment for multiple myeloma, including the newest, most advanced options. Our options include immunotherapy, CAR T cell therapy, and bloodless transplantation.
  • Specialized expertise: Multiple myeloma treatment has changed significantly in the past few years. New, more specific treatments are now available. Our physicians, pathologists and nurses have special training and experience exclusively in this disease. Our multiple myeloma team is best positioned to choose the appropriate therapy for you.
  • Help for even the most complex cases: Because we offer the most advanced treatment options, we can help the most complex cancers. Even if treatment elsewhere has not been successful, we might have options for you.
  • A history of leadership in multiple myeloma treatment: Penn is a longstanding international leader in the treatment of blood cancers. We helped develop many of the current treatments and teach others around the world about effective treatment.
National Cancer Institute Designated Comprehensive Cancer Center badge on top of shot of hospital

Rated “exceptional” by The National Cancer Institute

Penn Medicine’s Abramson Cancer Center is a world leader in cancer research, patient care, and education. Our status as a national leader in cancer care is reflected in our continuous designation as a Comprehensive Cancer Center by the National Cancer Institute (NCI) since 1973, one of 7 such centers in the United States. The ACC is also a member of the National Comprehensive Cancer Network, one of a select few cancer centers in the U.S., that are working to promote equitable access to high-quality, advanced cancer care.

Schedule an appointment

We can help you schedule an appointment or you can search our directory of specialists.